본문 바로가기
KERD
논문KCI 등재

A Pilot Study on Single-dose Toxicity Testing of Hominis placenta Pharmacopuncture in Sprague-Dawley Rats

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: This study was performed to analyze the toxicity and to find the lethal dose of the test substance Hominis placenta pharmacopuncture when used as a single-dose in 6 week old, male and female Sprague-Dawley (SD) rats. Methods: All experiments were conducted at Biotoxtech (Chungwon, Korea), an institution authorized to perform non clinical studies, under the regulations of Good Laboratory Practice (GLP). SD rats were chosen for the pilot study. Doses of Hominis placenta pharmacopuncture extracts, 0.125, 0.25 and 0.5 mL, were administered to the experimental group, and 0.5 mL doses of normal saline solution were administered to the control group. This study was conducted under the approval of the Institutional Animal Ethics Committee. Results: No deaths or abnormalities occurred in any of the groups. Also, no significant changes in body weights were observed among the groups, and no significant differences in hematology/biochemistry, necropsy, and histopathology results were noted. Hematologically, some changes in the male rats in two experimental groups were observed, but those changes had no clinical or toxicological meaning because they were not dose dependent. Histopathological tests on the injected parts showed cell infiltration in the male rats in one of the experimental groups; however, that result was due to spontaneous generation and had no toxicological meaning. Therefore, this study showed that Hominis placenta pharmacopuncture had no effect on the injected parts in terms of clinical signs, body weight, hematology, clinical chemistry, and necropsy. Conclusion: As a result of single-dose tests of the test substance Hominis placenta pharmacopuncture in 4 groups of rats, the lethal dose for both males and females exceeded 0.5 mL/animal. Therefore, the above findings suggest that treatment with Hominis placenta pharmacopuncture is relatively safe. Further studies on this subject are needed.

Abstract

Objectives: This study was performed to analyze the toxicity and to find the lethal dose of the test substance Hominis placenta pharmacopuncture when used as a single-dose in 6 week old, male and female Sprague-Dawley (SD) rats. Methods: All experiments were conducted at Biotoxtech (Chungwon, Korea), an institution authorized to perform non clinical studies, under the regulations of Good Laboratory Practice (GLP). SD rats were chosen for the pilot study. Doses of Hominis placenta pharmacopuncture extracts, 0.125, 0.25 and 0.5 mL, were administered to the experimental group, and 0.5 mL doses of normal saline solution were administered to the control group. This study was conducted under the approval of the Institutional Animal Ethics Committee. Results: No deaths or abnormalities occurred in any of the groups. Also, no significant changes in body weights were observed among the groups, and no significant differences in hematology/biochemistry, necropsy, and histopathology results were noted. Hematologically, some changes in the male rats in two experimental groups were observed, but those changes had no clinical or toxicological meaning because they were not dose dependent. Histopathological tests on the injected parts showed cell infiltration in the male rats in one of the experimental groups; however, that result was due to spontaneous generation and had no toxicological meaning. Therefore, this study showed that Hominis placenta pharmacopuncture had no effect on the injected parts in terms of clinical signs, body weight, hematology, clinical chemistry, and necropsy. Conclusion: As a result of single-dose tests of the test substance Hominis placenta pharmacopuncture in 4 groups of rats, the lethal dose for both males and females exceeded 0.5 mL/animal. Therefore, the above findings suggest that treatment with Hominis placenta pharmacopuncture is relatively safe. Further studies on this subject are needed.

참고문헌 (14)

  1. Korean pharmacopuncture institute, "Pharmacopuncturology", pp.3~ (2012), Elsevier Korea LLC
  2. Korean pharmacopuncture institute, "Pharmacopuncturology", pp.178~179 (2012), Elsevier Korea LLC
  3. Shibasaki T, "Corticotropin-releasing factor-like activity in human placental extracts", J Clin Endocrinol Metab, 55(2), pp.384~386 (1982)
  4. Bartlett MS, "Properties of sufficiency and statistical test", Proc R Soc Lond A, 160, pp.268~282 (1937)
  5. Dunnett CW, "New tables for multiple comparisons with control", Biometrics, 20(3), pp.482~491 (1964)
  6. Wynn SG, "Venterinary Acupuncture: Ancient Art to Modern Medicine", pp.53~57 (2001), Mosby
  7. Moore A, "Bandolier's little book of making sense of the medical evidence", pp.254~259 (2006), Oxford University Press
  8. 유화승, "자하거약침의 월경통에 대한 치료효과", Journal of Pharmacopuncture, 8(1), pp.45~49 (2005), 대한약침학회
  9. 육태한, "The Effect of Hominis Placenta Herbal Acupuncture on Bell's palsy", Journal of Pharmacopuncture, 3(1), pp.89~99 (2000), 대한약침학회[DOI]
  10. 이채우, "紫河車 藥鍼의 口眼喎斜에 대한 임상적 연구", Journal of Pharmacopuncture, 8(3), pp.87~97 (2005), 대한약침학회
  11. 장소영, "자하거 약침의 월경통에 대한 효과", 대한침구의학회지, 22(6), pp.85~92 (2005), 대한침구의학회
  12. 김수민, "월경곤란증의 자하거 약침효과에 관한 연구", Journal of Pharmacopuncture, 11(3), pp.123~131 (2008), 대한약침학회
  13. 강성길, "Effects of Hominis Placenta Aqua-acupuncture on Kidney and Liver Intoxicated by HgCI2 in Rats", Journal of Pharmacopuncture, 3(2), pp.191~212 (2000), 대한약침학회[DOI]
  14. 강형원, "Sprague-Dawley 랫드를 이용한 Up & Down 법 (UDP)에 의한 LMK02의 단회 경구투여 독성시험", 동의신경정신과학회지, 21(3), pp.87~93 (2010), 대한한방신경정신과학회

관련 논문AI추천

이 간행물의 다른 논문 (9건)